Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Navamedic ASA: Notice of Annual General Meeting

The annual general meeting of Navamedic ASA (OSE: NAVA) will be held on Tuesday, June 4th 2024 at 09:00 (CET) in the Navamedic offices in Henrik Ibsens gate 100, 0255 Oslo. The Notice of the Annual General Meeting is attached. The Notice is posted electronically or by mail to all shareholders and is available on the company's website https://navamedic.com/investors/general-meeting/. For further information, please contact: Kathrine G. Andreassen, CEO, Navamedic, Mobile: +47 951 78 680 E-mail: kathrine@navamedic.com Lars Hjarrand, CFO, Navamedic, Mobile: +47 917 62 842 E-mail: lars.

#24-48 Rights issue in Jumpgate AB

With the support of the authorization from the annual general meeting on June 27, 2023, the board of Jumpgate AB (“the Company”) has decided on a rights issue with preferential rights for the Company’s existing shareholders. The last day of trading in the Company’s shares including the right to receive subscription rights is May 16, 2024. The first day of trading in the Company’s shares excluding the right to receive subscription rights is May 17, 2024. The record date is May 20, 2024. The shareholders of the Company will receive one (1) subscription right for each share held per the

BlueNord: Minutes from Annual General Meeting

Oslo, 14 May 2024: BlueNord ASA (“BlueNord” or the "Company") has today held its annual general meeting (the "AGM") as a digital meeting through the solution Lumi AGM. All items on the agenda were resolved in accordance with the proposals. “I would like to use this opportunity to recognise the job that Mr Rustad has done for almost a decade developing and monetising what was originally largely a company with tax losses into what is today a significant European E&P company.  As a shareholder from the early days, and member of the board for the past three years, I’m confident that

Interim report January - March 2024

Challenging market conditions in Sweden – action program completed JANUARY - MARCH 2024 · Net sales amounted to MSEK 292.5 (370.3). · Net sales declined 21% (-3). · EBIT amounted to MSEK -6.7 (27.8). · EBIT margin amounted to -2.3% (7.5). · Net income was MSEK -8.1 (20.7). · Loss per share amounted to SEK -0.16 (earnings: 0.41). SIGNIFICANT EVENTS DURING AND AFTER THE QUARTER · During the quarter, the announced action and efficiency program was completed, resulting in 40 redundancies in the Group. · GARO E-mobility reported sales growth of 15% outside the

Polymer Factory’s SpheriCal® for IM-MS featured in scientific article

In a scientific article published in May 2024, Polymer Factory’s product manager Jens Sommertune has gathered a group of international mass spectrometry and ion mobility scientists to perform a proof-of-concept and suitability study on the use of compounds from Polymer Factory’s SpheriCal® platform to tune and calibrate Ion Mobility Mass Spectrometry (IM-MS) devices. IM-MS is an emerging analysis technique that allows for characterization and separation of molecules not only by their mass but also another dimension – the so-called collision cross section (CCS). This is of importance in,

SRV will implement a multipurpose building as a lifecycle project in Suutarila, Helsinki – focusing on ecology, sustainability and recycling

SRV GROUP PLC     INVESTOR NEWS           14 MAY 2024   14.15  EEST SRV will implement a multipurpose building as a lifecycle project in Suutarila, Helsinki – focusing on ecology, sustainability and recycling SRV and the City of Helsinki have signed an agreement to implement a multipurpose building under a lifecycle model in Suutarila, Helsinki. The total value of the agreement for SRV, including lifecycle services, is approximately EUR 56 million.The order for the construction is recognised in the order backlog in May. The project will be carried out in a lifecycle-wise manner, with

Environment Week 2024: Prof Klaus Kümmerer discusses Sustainable Chemistry

Director of the Research & Education Hub at ISC3 accepts the Federal President's invitation to Bellevue Palace in BerlinAt the invitation of Federal President Frank-Walter Steinmeier and the German Federal Environmental Foundation (DBU), Prof. Klaus Kümmerer will represent the International Sustainable Chemistry Collaboration Center (ISC3) at the “Week of the Environment” (German: Woche der Umwelt) event on 4 and 5 June 2024 in Berlin. As part of the innovation show with 190 exhibitors, more than 70 specialist forums and exciting discussions with high-ranking experts, the Director of the

OKEA ASA - Minutes of annual general meeting

(Trondheim, 14 May 2024) OKEA ASA (OSE: OKEA): On 14 May 2024 at 09:00 CET OKEA ASA held an annual general meeting as a virtual meeting with online participation. All proposals on the agenda were adopted. The minutes of meeting are attached and also available on https://www.okea.no/investor/general-meetings/. At the general meeting, Chaiwat Kovavisarach was re-elected as chairman of the board for a period of two years. The board of directors in OKEA ASA subsequently consists of the following shareholder-elected members: · Chaiwat Kovavisarach (Chairman) · Mike Fischer (vice

Calliditas’ Partner Everest Medicines Starts Commercial Launch of Nefecon in China

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announces that its partner Everest Medicines (HKEX: 1952.HK) (“Everest”) has launched Nefecon® in China.China, which is estimated to have up to 5 million patients suffering from the progressive autoimmune disease, IgA nephropathy (IgAN), has the highest prevalence of primary glomerular diseases in the world, with IgAN accounting for about 35% to 50% of cases with a biopsy proven incidence of over 100,000 patients per year. There is a very significant unmet medical need for novel therapies among IgAN

Finland’s third largest wind farm inaugurated in Pjelax

FORTUM CORPORATION PRESS RELEASE 14.5.2024 The Pjelax wind farm of 56 wind turbines, a joint project between Finnish energy companies Fortum and Helen, was inaugurated on Tuesday, 14 May 2024. Located in the areas of Närpiö and Kristiinankaupunki in western Finland, the wind farm will produce more than 1 TWh of wind power annually, around 5% of Finland’s total wind power production. Fortum owns 60% of the wind farm, while Helen owns 40%. Helen will purchase around 50% of the wind farm’s electricity production until the end of its life cycle. “With 380 MW, Pjelax will double the wind

Change in management team of Rugvista

Rugvista hereby announces a change in the management team where CDPO (Chief Design and Purchasing Officer) Carin Terins leaves Carin Terins joined Rugvista in 2018 and has as CDPO been responsible for Rugvista’s design- and purchase function. Carin Terins has announced that she has decided to leave Rugvista. Carin will continue in duty until June 2024 after which the CEO will assume the operational responsibility for the assortment- and purchase function until further notice. ”I want to extend my thanks to Carin for her fantastic commitment and efforts during her time at Rugvista

Investment after the completion of the new share issue

VibroSense gains new momentum after the completion of the new share issue and increases investment in existing markets. At the same time, the company plans to gear up with more activities to reach out to new countries and thereby accelerate the company's sales.VibroSense will mainly focus the use of the issue proceeds in the areas of sales and marketing, which is completely in line with what was communicated before the recently concluded new share issue.OrganizationThe company will strengthen its own organization in the area of sales, but also take new approaches with foreign partners

Net Asset Value(s)

MITON UK MICROCAP TRUST PLC Miton UK MicroCap Trust plc 14 May 2024 Miton UK Microcap Trust plc It is announced that at the close of business on 13 May 2024, the unaudited Net Asset Value per share of Miton UK Microcap Trust plc is: With the portfolio valued on a fair value basis: Including current period revenue to 13 May 2024                                                56.80p per ordinary share Excluding current period revenue                56.70p per ordinary share Legal Entity

UPM Raflatac introduces new wave for plastic packaging: The world’s first RecyClass certified paper label for rigid HDPE and PP

(UPM Raflatac, Helsinki, 14 May 2024 at 13:00 EEST) – UPM Raflatac has announced the launch of its innovative New Wave paper label material compatible with recycling. It is the first RecyClass certified paper label material to obtain a Letter of Compatibility for use on rigid high-density polyethylene (HDPE) and polypropylene (PP) containers. The test results confirm the compatibility even for natural and white material streams, which require the highest purity of recyclate from the recycling processes. This groundbreaking new label material represents a major step forward in the recycling

Viaplay Group 2024 Annual General Meeting

Viaplay Group AB (publ) (“Viaplay Group”) held its Annual General Meeting (“AGM”) today. The AGM resolved to elect Katarina Bonde, Anna Bäck, Simon Duffy, Erik Forsberg, Andrea Gisle Joosen, Jacques du Puy, Maxime Saada, Didier Stoessel and Annica Witschard as members of the Board of Directors until the end of the next AGM. Simon Duffy was elected as Chair of the Board of Directors. The AGM adopted the Income Statement and the Balance Sheet, along with the consolidated Income Statement and the consolidated Balance Sheet. Furthermore, the AGM resolved that Viaplay Group’s

Finnfund’s investment portfolio grew up to EUR 830 million – more focus on digitalisation and mobilisation of private capital

Finnfund, a Finnish development financier and impact investor, has published its Annual Report 2023. The report collates key information about Finnfund’s financial performance, sustainability, and impact. Last year, the company’s investment portfolio grew from EUR 810 million to EUR 830 million. Finnfund’s investments, commitments, and investment decisions totalled about EUR 1.23 billion at the end of the year. Africa remained Finnfund’s primary investment destination, accounting for 46% of volume and 30% of decisions. “I am pleased to say that, despite the somewhat challenging

Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting

At Bactiguard Holding AB’s (publ) Annual General Meeting (AGM) on 14 May 2024, the following resolutions were made:The AGM adopted the income statements and balance sheets for 2023 and decided that no dividend for the financial year 2023 will be paid. Retained earnings and the company's result for the year will be carried forward. The Board of Directors and CEOs were discharged from liability for their administration of the company for the financial year 2023. The AGM resolved that the remuneration until the next AGM shall be paid in an amount of SEK 750 000 to the Chairman of the

Tranter and Hexxcell forge strategic partnership to revolutionize industrial heat exchanger maintenance.

Houston, Texas, USA, and London, UK, May 14 2024 - Tranter Inc., a global leader in heat exchanger solutions, and Hexxcell Ltd., an innovative provider of digital technology for industrial heat transfer systems, are proud to announce a strategic partnership to transform the monitoring and predictive maintenance of industrial plate and frame heat exchangers. This collaboration, focused on driving operational efficiency, reducing costs, and identifying sustainable opportunities for our customers, marks a significant milestone in the industry.Combining Tranter's extensive global expertise in

BioStock: Aqilion aims for best-in-class with new programme

Aqilion is in the business of discovering and developing new drug targets that could reduce the burden of chronic inflammatory illnesses. The company has three ongoing pipeline projects, and a fourth programme has just been announced with PKCtheta as the target. Aqilion’s CEO Sarah Fredriksson joined us in the studio to tell us all about it!Watch the interview at biostock.se: Aqilion aims for best-in-class with new programme - BioStock This is a press release from BioStock - Connecting Innovation &

Gentle reminder: Kesko investor event 4 June 2024

Kesko invites investors, analysts and media to its investor event in Helsinki on Tuesday, 4 June 2024, from 4 pm to 6 pm (EEST).   At the event, President and CEO Jorma Rauhala and other members of Kesko’s top management discuss the company’s updated strategy and focus areas for the three business divisions – grocery trade, building and technical trade, and car trade – and other topical themes. The event will be held in English.  The event will take place at Kesko’s K-Kampus headquarters in Kalasatama, Helsinki, street address Työpajankatu 12. The event can also be viewed via a live

Paindrainer’s digital medical device approved for a clinical study investigating its effect on brain activities

MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB is pleased to announce the approval of a clinical study of the effect of Paindrainer's digital medical device on brain activities.The Paindrainer digital medical device will be used to investigate how chronic pain is processed in the brain using Cleveland Clinic’s established brain scanning technology, as well as evaluate the correlation between users' logged data and objectively measured real world data through wearables. The study will be held at Cleveland Clinic in collaboration with Lund University. “It is a unique opportunity and very

Paindrainer’s digital medical device approved for a clinical study investigating its effect on brain activities

MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB is pleased to announce the approval of a clinical study of the effect of Paindrainer's digital medical device on brain activities.The Paindrainer digital medical device will be used to investigate how chronic pain is processed in the brain using Cleveland Clinic’s established brain scanning technology, as well as evaluate the correlation between users' logged data and objectively measured real world data through wearables. The study will be held at Cleveland Clinic in collaboration with Lund University. “It is a unique opportunity and very

Welcome to cover the 2024 Astrid Lindgren Memorial Award Ceremony

On Tuesday, June 4, the Australian organisation Indigenous Literacy Foundation will receive the 2024 Astrid Lindgren Memorial Award at Konserthuset in Stockholm. The award diploma will be presented by HRH Crown Princess Victoria of Sweden.Time: Tuesday, June 4 at 18-19 CET. The seats must be taken at latest 17:45. Place: Konserthuset, Stockholm During a grand evening, we celebrate Indigenous Literacy Foundation and their work. The host of the evening is Marie Agerhäll. AccreditationJournalists/photographers who wish to attend need to pre-register no later than 3:00 p.m. on June 3.

Dedicare Implements Management Changes in Sweden and Initiates Cost-Saving Program

Dedicare is undergoing a management change in Sweden, where Bård Kristiansen, CEO of Dedicare Norway since 2017, will take over as interim CEO for Dedicare Sweden. Bård will continue as CEO for Dedicare Norway, while Lene Langås, operational manager within nurse staffing since 2013, will be appointed as interim operational manager for the Norwegian operations. The process of recruiting a new CEO for Dedicare Sweden will commence immediately. Eva Brunnberg is leaving the company, at her own request, and thereby vacating the position of CEO for Dedicare Sweden. "Bård has successfully built

There are no items matching the current filter
There are no more items matching the current filter
Back to top